High APACHE II score and long length of bowel resection impair the outcomes in patients with necrotic bowel induced hepatic portal venous gas

BMC Gastroenterology

Research Article

Tzu-Hsin Lin¹  Ming-Shian Tsai²  Jin-Ming Wu³  Yu-Wen Tien³  Ming-Tsan Lin³ 

[1] Department of Traumatology, National Taiwan University Hospital, Taipei, Taiwan;Division of General Surgery, Department of Surgery, E-Da Hospital, Kaohsiung, Taiwan;Division of General Surgery, Department of Surgery, National Taiwan University, Hospital, Taipei, Taiwan;

关键词: Bowel Resection;    Mesenteric Ischemia;    Small Bowel Resection;    Ischemic Bowel;    Intestinal Necrosis;   

DOI  :  10.1186/1471-230X-11-18

 received in 2010-07-24, accepted in 2011-03-09,  发布年份 2011

来源: Springer

【 摘 要 】

BackgroundHepatic portal venous gas (HPVG) is a rare but potentially lethal condition, especially when it results from intestinal ischemia. Since the literatures regarding the prognostic factors of HPVG are still scarce, we aimed to investigate the risk factor of perioperative mortality in this study.MethodsWe analyzed data for patients with intestinal ischemia induced HPVG by chart review in our hospital between 2000 and 2007. Factors associated with perioperative mortality were specifically analyzed.ResultsThere were 22 consecutive patients receiving definite bowel resection. 13 cases (59.1%) died after surgical intervention. When analyzing the mortality in patients after bowel resections, high Acute Physiology And Chronic health Evaluation (APACHE) II score (p < 0.01) and longer length of bowel resection (p = 0.047) were significantly associated with mortality in univariate analyses. The complication rate was 66.7% in alive patients after definite bowel resection.ConclusionsBowel resection was the only potential life-saving therapy for patients with mesenteric ischemia induced HPVG. High APACHE II score and severity of underlying necrotic bowel determined the results in patients after bowel resection.

【 授权许可】

Unknown   
© Wu et al; licensee BioMed Central Ltd. 2011. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.